5.9K(top 5%)
articles
271.5K(top 3%)
citations
2,050(top 3%)
★★ articles
64(top 4%)
★★★ articles
3.8(top 7%)
Avg IF
201(top 3%)
H-Index
336(top 3%)
G-Index
1,085
journals

Most Cited Articles of University of Pittsburgh Cancer Institute in 1999

TitleJournalYearCitations
Socioeconomic status and chronic stress. Does stress account for SES effects on health?Annals of the New York Academy of Sciences1999486
Possible role of ovarian epithelial inflammation in ovarian cancerJournal of the National Cancer Institute1999447
Health psychology: mapping biobehavioral contributions to health and illnessAnnual Review of Psychology1999293
Immunotherapy of NOD mice with bone marrow-derived dendritic cellsDiabetes1999158
Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytesCancer Research1999150
Th1/Th2 balance in cancer, transplantation and pregnancySeminars in Immunopathology1999148
When god disappoints: difficulty forgiving god and its role in negative emotionJournal of Health Psychology1999147
Epidermal growth factor receptor expression and gene amplification in high-grade non-brainstem gliomas of childhoodClinical Cancer Research1999146
Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12Cancer Research1999142
Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cellsJournal of Immunology1999140
Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectivelyJournal of Immunology1999131
Intratracheal injection of adenovirus containing the human MnSOD transgene protects athymic nude mice from irradiation-induced organizing alveolitisInternational Journal of Radiation Oncology Biology Physics1999125
C-myc overexpression and p53 loss cooperate to promote genomic instabilityOncogene1999121
A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancyClinical Cancer Research1999114
Plasma pharmacokinetics of butyrate after intravenous administration of sodium butyrate or oral administration of tributyrin or sodium butyrate to mice and ratsCancer Chemotherapy and Pharmacology1999109
1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivoCancer Research1999104
Clinical significance of decreased zeta chain expression in peripheral blood lymphocytes of patients with head and neck cancerClinical Cancer Research199991
Manganese [correction of Magnesium] superoxide dismutase (MnSOD) plasmid/liposome pulmonary radioprotective gene therapy: modulation of irradiation-induced mRNA for IL-I, TNF-alpha, and TGF-beta correlates with delay of organizing alveolitis/fibrosisBiology of Blood and Marrow Transplantation199989
Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccineGene Therapy199986
Evidence for autocrine actions of neuromedin B and gastrin-releasing peptide in non-small cell lung cancerPulmonary Pharmacology and Therapeutics199986
Phase I trial, including pharmacokinetic and pharmacodynamic correlations, of combination paclitaxel and carboplatin in patients with metastatic non-small-cell lung cancerJournal of Clinical Oncology199982
Tumor's other immune targets: dendritic cellsJournal of Leukocyte Biology199978
Binding and uptake of agalactosyl IgG by mannose receptor on macrophages and dendritic cellsJournal of Immunology199978
Subcellular and Cell-Cycle Expression Profiles of CDK-Inhibitors in Normal Differentiating Myeloid CellsBlood199976
Prevention of irradiation-induced esophagitis by plasmid/liposome delivery of the human manganese superoxide dismutase transgeneRadiation Oncology Investigations199971